Director, Cell Therapy WW Medical Affairs, Myeloma

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

Reporting to the Executive Director, Cell Therapy Multiple Myeloma, the Director, WW Medical, Multiple Myeloma Cell Therapy Pipeline will represent WW Medical Affairs as a therapeutic area expert and provide scientific leadership across MM CAR T assets at various stages of clinical development.

This individual will be responsible for building and executing medical strategy across the MM Cell Therapy pipeline, including external communications, market shaping, internal readiness, and strategic partnership across the matrix. The role requires depth of scientific expertise, credibility with external thought leaders, and the composure to operate effectively at the intersection of WW commercialization, local Medical Affairs, and global Clinical Development.

• Strategic Leadership of Multiple Myeloma Pipeline Assets
• Define and lead the integrated Medical Affairs plan across MM Cell Therapy pipeline assets, in full alignment with commercialization and development strategies
• Represent MM Cell Therapy pipeline assets and strategy at AIMS, ensuring alignment of global Medical Affairs direction across key medical functions and markets
• Collaborate with local Medical Affairs teams to align on disease strategy and tactics, ensuring cohesive action plans across markets
• Drive cross-asset collaboration and knowledge sharing, fostering a unified BMS presence in multiple myeloma, including partnerships across Cell Therapy and Hematology
• Establish and cultivate relationships with key thought leaders in the field
• Seamless Execution of Core Medical Affairs Deliverables
• Develop and execute medical plans aligned to overall asset strategy across the MM Cell Therapy pipeline
• Provide strategic input to guide publication planning and execution; serve as a key reviewer on abstracts, presentations, and publications
• Develop and implement congress strategies to achieve impactful scientific presence and engagement at major meetings including COMy, EHA, and IMS
• Organize and provide strategic input into BMS-sponsored symposia and independent medical education events to enhance scientific dialogue
• Refine Integrated Evidence Plans (IEP) across pipeline assets to ensure alignment with cross-functional goals; provide expert review and recommendations for new ISR and CRC trials as well as HEOR analyses
• Conduct comprehensive reviews of publications and update key medical assets, including slide decks, training sessions, and Q&A materials
• Serve as a credible external representative of BMS in MM Cell Therapy, engaging thought leaders, cooperative groups, steering committees, and advisory boards to generate insights and shape the evolving treatment paradigm
• Ensure scientific excellence in medical education and effective data exchange
• Provide Scientific/Medical Expertise Across the Matrix
• Offer medical insights to guide clinical development plans and influence strategic decision-making for both early and late development across the MM pipeline
• Serve as subject matter expert to cross-functional partners in multiple myeloma, providing guidance at both the asset and portfolio level
• Collaborate with global and local market access and marketing teams, providing expert…